407 related articles for article (PubMed ID: 12510804)
1. Nitric oxide promotes infectious bone resorption by enhancing cytokine-stimulated interstitial collagenase synthesis in osteoblasts.
Lin SK; Kok SH; Kuo MY; Lee MS; Wang CC; Lan WH; Hsiao M; Goldring SR; Hong CY
J Bone Miner Res; 2003 Jan; 18(1):39-46. PubMed ID: 12510804
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide promotes the progression of periapical lesion via inducing macrophage and osteoblast apoptosis.
Lin SK; Kok SH; Lin LD; Wang CC; Kuo MY; Lin CT; Hsiao M; Hong CY
Oral Microbiol Immunol; 2007 Feb; 22(1):24-9. PubMed ID: 17241167
[TBL] [Abstract][Full Text] [Related]
3. Inducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone explants is associated with suppression of osteoclastic bone resorption.
Löwik CW; Nibbering PH; van de Ruit M; Papapoulos SE
J Clin Invest; 1994 Apr; 93(4):1465-72. PubMed ID: 8163651
[TBL] [Abstract][Full Text] [Related]
4. Macrophage inflammatory protein-1 alpha production in lipopolysaccharide-stimulated human adherent blood mononuclear cells is inhibited by the nitric oxide synthase inhibitor N(G)-monomethyl-L-arginine.
Mühl H; Dinarello CA
J Immunol; 1997 Nov; 159(10):5063-9. PubMed ID: 9366434
[TBL] [Abstract][Full Text] [Related]
5. Cytokine-induced nitric oxide inhibits bone resorption by inducing apoptosis of osteoclast progenitors and suppressing osteoclast activity.
van't Hof RJ; Ralston SH
J Bone Miner Res; 1997 Nov; 12(11):1797-804. PubMed ID: 9383684
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia enhances gene expression of inducible nitric oxide synthase and matrix metalloproteinase-9 in ras/myc-transformed serum-free mouse embryo cells under simulated inflammatory and infectious conditions.
Yamaguchi H; Kidachi Y; Umetsu H; Ryoyama K
Cell Biol Int; 2008 Aug; 32(8):940-9. PubMed ID: 18474440
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of heme-binding protein 23 (HBP23) gene expression by lipopolysaccharide is mediated via a nitric oxide-dependent signaling pathway in rat Kupffer cells.
Immenschuh S; Stritzke J; Iwahara S; Ramadori G
Hepatology; 1999 Jul; 30(1):118-27. PubMed ID: 10385647
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide: a cytokine-induced regulator of bone resorption.
Ralston SH; Ho LP; Helfrich MH; Grabowski PS; Johnston PW; Benjamin N
J Bone Miner Res; 1995 Jul; 10(7):1040-9. PubMed ID: 7484279
[TBL] [Abstract][Full Text] [Related]
9. [Effects of insulin-like growth factor II on regulating nitric oxide synthase gene expression in mouse osteoblast-like MC3T3-E1 cells].
Sun WL; Chen LL; Yan J; Yu ZS
Zhonghua Kou Qiang Yi Xue Za Zhi; 2004 May; 39(3):201-4. PubMed ID: 15196385
[TBL] [Abstract][Full Text] [Related]
10. Regulation of inducible nitric oxide synthase messenger RNA expression and nitric oxide production by lipopolysaccharide in vivo: the roles of macrophages, endogenous IFN-gamma, and TNF receptor-1-mediated signaling.
Salkowski CA; Detore G; McNally R; van Rooijen N; Vogel SN
J Immunol; 1997 Jan; 158(2):905-12. PubMed ID: 8993010
[TBL] [Abstract][Full Text] [Related]
11. Cbfa-1 mediates nitric oxide regulation of MMP-13 in osteoblasts.
Zaragoza C; López-Rivera E; García-Rama C; Saura M; Martínez-Ruíz A; Lizarbe TR; Martín-de-Lara F; Lamas S
J Cell Sci; 2006 May; 119(Pt 9):1896-902. PubMed ID: 16636074
[TBL] [Abstract][Full Text] [Related]
12. Minocycline inhibits apoptotic cell death via attenuation of TNF-alpha expression following iNOS/NO induction by lipopolysaccharide in neuron/glia co-cultures.
Lee SM; Yune TY; Kim SJ; Kim YC; Oh YJ; Markelonis GJ; Oh TH
J Neurochem; 2004 Nov; 91(3):568-78. PubMed ID: 15485488
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta 1 primes macrophages for enhanced expression of the nitric oxide synthase gene for nitric oxide-dependent cytotoxicity against Entamoeba histolytica.
Lin JY; Seguin R; Keller K; Chadee K
Immunology; 1995 Jul; 85(3):400-7. PubMed ID: 7558128
[TBL] [Abstract][Full Text] [Related]
14. Ruthenium complexes as nitric oxide scavengers: a potential therapeutic approach to nitric oxide-mediated diseases.
Fricker SP; Slade E; Powell NA; Vaughan OJ; Henderson GR; Murrer BA; Megson IL; Bisland SK; Flitney FW
Br J Pharmacol; 1997 Dec; 122(7):1441-9. PubMed ID: 9421293
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide synthase inhibitors modulate lipopolysaccharide-induced hepatocyte injury: dissociation between in vivo and in vitro effects.
Farghali H; Canová N; Kucera T; Martínek J; Masek K
Int Immunopharmacol; 2003 Nov; 3(12):1627-38. PubMed ID: 14555288
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effects of cyclooxygenase-2 inhibitor celecoxib against toxicity of LPS-stimulated macrophages toward motor neurons.
Huang Y; Liu J; Wang LZ; Zhang WY; Zhu XZ
Acta Pharmacol Sin; 2005 Aug; 26(8):952-8. PubMed ID: 16038627
[TBL] [Abstract][Full Text] [Related]
17. Induction of nitric oxide production by bovine alveolar macrophages in response to Pasteurella haemolytica A1.
Yoo HS; Rutherford MS; Maheswaran SK; Srinand S; Ames TR
Microb Pathog; 1996 Jun; 20(6):361-75. PubMed ID: 8831831
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide synthase is induced in tumor promoter-sensitive, but not tumor promoter-resistant, JB6 mouse epidermal cells cocultured with interferon-gamma-stimulated RAW 264.7 cells: the role of tumor necrosis factor-alpha.
Murakami A; Kawabata K; Koshiba T; Gao G; Nakamura Y; Koshimizu K; Ohigashi H
Cancer Res; 2000 Nov; 60(22):6326-31. PubMed ID: 11103793
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide acts in conjunction with proinflammatory cytokines to promote cell death in osteoblasts.
Damoulis PD; Hauschka PV
J Bone Miner Res; 1997 Mar; 12(3):412-22. PubMed ID: 9076584
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of ornithine decarboxylase potentiates nitric oxide production in LPS-activated J774 cells.
Baydoun AR; Morgan DM
Br J Pharmacol; 1998 Dec; 125(7):1511-6. PubMed ID: 9884080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
